Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $AMRX vs $MANE | Chartloom

Compare

$AMRX vs $MANE

Amneal Pharmaceuticals Inc · Veradermics Inc

AMRX

Amneal Pharmaceuticals Inc

MANE

Veradermics Inc

Compare $AMRX vs $MANE

Comparing Amneal Pharmaceuticals Inc and Veradermics Inc

AMRXAmneal Pharmaceuticals Inc

MANEVeradermics Inc

AMRXAmneal Pharmaceuticals Inc

Market cap

$6.25B

P/E (TTM)

40.80x

Forward P/E (NTM)

19.08x

Forward P/S (NTM)

1.89x

Rev growth (TTM)

9.3%

YTD performance

54.6%

52W performance

96.3%

FCF yield

-0.2%

MANEVeradermics Inc

Market cap

$4.86B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

208.0%

52W performance

208.0%

FCF yield

-2.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AMRX

MANE

Detailed metrics comparison

AMRX

Amneal Pharmaceuticals Inc

MANE

Veradermics Inc

Market Cap

AMRX$6.25B

MANE$4.86B

Enterprise Value

AMRX$8.85B

MANE$4.54B

Price

AMRX$19.57

MANE$116.26

P/E Ratio

AMRX40.80x

MANEN/A

P/S Ratio

AMRX2.00x

MANE0.00x

EV/Sales

AMRX2.84x

MANE0.00x

EV/EBITDA

AMRX13.14x

MANE0.00x

P/B Ratio

AMRX192.54x

MANE6.72x

P/FCF Ratio

AMRXN/A

MANEN/A

EV/FCF

AMRX-719.11x

MANE-42.29x

PEG Ratio

AMRX1.98x

MANEN/A

Forward P/E (NTM)

AMRX19.08x

MANEN/A

Forward P/S (NTM)

AMRX1.89x

MANEN/A

Revenue (TTM)

AMRX$3.12B

MANE$0

Revenue Growth (YoY)

AMRX9.3%

MANEN/A

Forward Rev Growth

AMRX9.0%

MANE308.7%

Gross Margin (TTM)

AMRX39.3%

MANE0.0%

Operating Margin (TTM)

AMRX14.6%

MANE0.0%

EBITDA Margin (TTM)

AMRX21.6%

MANE0.0%

Net Margin (TTM)

AMRX5.0%

MANE0.0%

FCF Margin (TTM)

AMRX-0.4%

MANEN/A

Net Income (TTM)

AMRX$157M

MANE$-137M

FCF (TTM)

AMRX$-12M

MANE$-107M

EPS (TTM)

AMRX$0.48

MANE-$3.39

ROE (TTM)

AMRX174.6%

MANE-3549.0%

ROA (TTM)

AMRX4.3%

MANE-3463.0%

ROIC (TTM)

AMRX2.1%

MANE-3549.0%

Cash

AMRX$128M

MANE$319M

Debt

AMRX$2.73B

MANE$0

Net Cash/Debt

AMRX$-2.60B

MANE$319M

Current Ratio (TTM)

AMRX2.20x

MANE70.53x

Quick Ratio (TTM)

AMRX1.38x

MANE70.35x

Debt/Equity (TTM)

AMRX82.62x

MANE0.00x

Debt/Assets (TTM)

AMRX0.0%

MANE0.0%

Interest Coverage (TTM)

AMRXN/A

MANEN/A

Net Debt/EBITDA (TTM)

AMRX0.00x

MANE0.00x

Beta

AMRX1.22

MANE-0.05

52W Performance

AMRX96.3%

MANE208.0%

YTD Performance

AMRX54.6%

MANE208.0%

% from 52W High

AMRX-7.6%

MANE-15.0%

% from 52W Low

AMRX104.7%

MANE263.3%

Asset Turnover (TTM)

AMRX0.85x

MANE0.00x

FCF Yield (TTM)

AMRX-0.2%

MANE-2.2%

Earnings Yield (TTM)

AMRX2.5%

MANE-2.8%

Dividend Yield (TTM)

AMRXN/A

MANEN/A

Rule of 40

AMRX8.9

MANE0.0

EV/GP/RG

AMRX1.16

MANEN/A

Ticker research

View AMRX research View MANE research

Metric	AMRX Amneal Pharmaceuticals Inc	MANE Veradermics Inc
Market & Valuation
Market Cap	$6.25B	$4.86B
Enterprise Value	$8.85B	$4.54B
Price	$19.57	$116.26
P/E Ratio	40.80x	N/A
P/S Ratio	2.00x	0.00x
EV/Sales	2.84x	0.00x
EV/EBITDA	13.14x	0.00x
P/B Ratio	192.54x	6.72x
P/FCF Ratio	N/A	N/A
EV/FCF	-719.11x	-42.29x
PEG Ratio	1.98x	N/A
Forward P/E (NTM)	19.08x	N/A
Forward P/S (NTM)	1.89x	N/A
Revenue & Growth
Revenue (TTM)	$3.12B	$0
Revenue Growth (YoY)	9.3%	N/A
Forward Rev Growth	9.0%	308.7%
Profitability
Gross Margin (TTM)	39.3%	0.0%
Operating Margin (TTM)	14.6%	0.0%
EBITDA Margin (TTM)	21.6%	0.0%
Net Margin (TTM)	5.0%	0.0%
FCF Margin (TTM)	-0.4%	N/A
Net Income (TTM)	$157M	$-137M
FCF (TTM)	$-12M	$-107M
EPS (TTM)	$0.48	-$3.39
ROE (TTM)	174.6%	-3549.0%
ROA (TTM)	4.3%	-3463.0%
ROIC (TTM)	2.1%	-3549.0%
Financial Health
Cash	$128M	$319M
Debt	$2.73B	$0
Net Cash/Debt	$-2.60B	$319M
Current Ratio (TTM)	2.20x	70.53x
Quick Ratio (TTM)	1.38x	70.35x
Debt/Equity (TTM)	82.62x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.22	-0.05
52W Performance	96.3%	208.0%
YTD Performance	54.6%	208.0%
% from 52W High	-7.6%	-15.0%
% from 52W Low	104.7%	263.3%
Efficiency & Yields
Asset Turnover (TTM)	0.85x	0.00x
FCF Yield (TTM)	-0.2%	-2.2%
Earnings Yield (TTM)	2.5%	-2.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	8.9	0.0
EV/GP/RG	1.16	N/A
Ticker research	View AMRX research	View MANE research

Valuation

P/E Ratio

AMRX

40.80x

P/S Ratio

MANE

0.00x

AMRX

2.00x

EV/FCF

AMRX

-719.11x

MANE

-42.29x

Growth & revenue

Revenue Growth TTM

AMRX

9.3%

Forward Revenue Growth

MANE

308.7%

AMRX

9.0%

Profitability & performance

Gross Margin

AMRX

39.3%

MANE

0.0%

ROE

AMRX

174.6%

MANE

-3549.0%

FCF Yield %

AMRX

-0.2%

MANE

-2.2%

52-Week Performance

MANE

208.0%

AMRX

96.3%

Detailed metrics comparison

AMRX

Amneal Pharmaceuticals Inc

MANE

Veradermics Inc

Market Cap

AMRX$6.25B

MANE$4.86B

Enterprise Value

AMRX$8.85B

MANE$4.54B

Price

AMRX$19.57

MANE$116.26

P/E Ratio

AMRX40.80x

MANEN/A

P/S Ratio

AMRX2.00x

MANE0.00x

EV/Sales

AMRX2.84x

MANE0.00x

EV/EBITDA

AMRX13.14x

MANE0.00x

P/B Ratio

AMRX192.54x

MANE6.72x

P/FCF Ratio

AMRXN/A

MANEN/A

EV/FCF

AMRX-719.11x

MANE-42.29x

PEG Ratio

AMRX1.98x

MANEN/A

Forward P/E (NTM)

AMRX19.08x

MANEN/A

Forward P/S (NTM)

AMRX1.89x

MANEN/A

Revenue (TTM)

AMRX$3.12B

MANE$0

Revenue Growth (YoY)

AMRX9.3%

MANEN/A

Forward Rev Growth

AMRX9.0%

MANE308.7%

Gross Margin (TTM)

AMRX39.3%

MANE0.0%

Operating Margin (TTM)

AMRX14.6%

MANE0.0%

EBITDA Margin (TTM)

AMRX21.6%

MANE0.0%

Net Margin (TTM)

AMRX5.0%

MANE0.0%

FCF Margin (TTM)

AMRX-0.4%

MANEN/A

Net Income (TTM)

AMRX$157M

MANE$-137M

FCF (TTM)

AMRX$-12M

MANE$-107M

EPS (TTM)

AMRX$0.48

MANE-$3.39

ROE (TTM)

AMRX174.6%

MANE-3549.0%

ROA (TTM)

AMRX4.3%

MANE-3463.0%

ROIC (TTM)

AMRX2.1%

MANE-3549.0%

Cash

AMRX$128M

MANE$319M

Debt

AMRX$2.73B

MANE$0

Net Cash/Debt

AMRX$-2.60B

MANE$319M

Current Ratio (TTM)

AMRX2.20x

MANE70.53x

Quick Ratio (TTM)

AMRX1.38x

MANE70.35x

Debt/Equity (TTM)

AMRX82.62x

MANE0.00x

Debt/Assets (TTM)

AMRX0.0%

MANE0.0%

Interest Coverage (TTM)

AMRXN/A

MANEN/A

Net Debt/EBITDA (TTM)

AMRX0.00x

MANE0.00x

Beta

AMRX1.22

MANE-0.05

52W Performance

AMRX96.3%

MANE208.0%

YTD Performance

AMRX54.6%

MANE208.0%

% from 52W High

AMRX-7.6%

MANE-15.0%

% from 52W Low

AMRX104.7%

MANE263.3%

Asset Turnover (TTM)

AMRX0.85x

MANE0.00x

FCF Yield (TTM)

AMRX-0.2%

MANE-2.2%

Earnings Yield (TTM)

AMRX2.5%

MANE-2.8%

Dividend Yield (TTM)

AMRXN/A

MANEN/A

Rule of 40

AMRX8.9

MANE0.0

EV/GP/RG

AMRX1.16

MANEN/A

Ticker research

View AMRX research View MANE research

Metric	AMRX Amneal Pharmaceuticals Inc	MANE Veradermics Inc
Market & Valuation
Market Cap	$6.25B	$4.86B
Enterprise Value	$8.85B	$4.54B
Price	$19.57	$116.26
P/E Ratio	40.80x	N/A
P/S Ratio	2.00x	0.00x
EV/Sales	2.84x	0.00x
EV/EBITDA	13.14x	0.00x
P/B Ratio	192.54x	6.72x
P/FCF Ratio	N/A	N/A
EV/FCF	-719.11x	-42.29x
PEG Ratio	1.98x	N/A
Forward P/E (NTM)	19.08x	N/A
Forward P/S (NTM)	1.89x	N/A
Revenue & Growth
Revenue (TTM)	$3.12B	$0
Revenue Growth (YoY)	9.3%	N/A
Forward Rev Growth	9.0%	308.7%
Profitability
Gross Margin (TTM)	39.3%	0.0%
Operating Margin (TTM)	14.6%	0.0%
EBITDA Margin (TTM)	21.6%	0.0%
Net Margin (TTM)	5.0%	0.0%
FCF Margin (TTM)	-0.4%	N/A
Net Income (TTM)	$157M	$-137M
FCF (TTM)	$-12M	$-107M
EPS (TTM)	$0.48	-$3.39
ROE (TTM)	174.6%	-3549.0%
ROA (TTM)	4.3%	-3463.0%
ROIC (TTM)	2.1%	-3549.0%
Financial Health
Cash	$128M	$319M
Debt	$2.73B	$0
Net Cash/Debt	$-2.60B	$319M
Current Ratio (TTM)	2.20x	70.53x
Quick Ratio (TTM)	1.38x	70.35x
Debt/Equity (TTM)	82.62x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.22	-0.05
52W Performance	96.3%	208.0%
YTD Performance	54.6%	208.0%
% from 52W High	-7.6%	-15.0%
% from 52W Low	104.7%	263.3%
Efficiency & Yields
Asset Turnover (TTM)	0.85x	0.00x
FCF Yield (TTM)	-0.2%	-2.2%
Earnings Yield (TTM)	2.5%	-2.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	8.9	0.0
EV/GP/RG	1.16	N/A
Ticker research	View AMRX research	View MANE research